Iradimed Corp. (IRMD) Tops Q1 EPS by 3c; Boosts FY16 EPS Outlook
Get Alerts IRMD Hot Sheet
Join SI Premium – FREE
Iradimed Corp. (NASDAQ: IRMD) reported Q1 EPS of $0.21, $0.03 better than the analyst estimate of $0.18. Revenue for the quarter came in at $8.96 million versus the consensus estimate of $9.05 million.
GUIDANCE:
Iradimed Corp. sees FY2016 EPS of $0.21-$0.22, versus the consensus of $0.20. Iradimed Corp. sees FY2016 revenue of $9.6-9.7 million, versus the consensus of $9.32 million.
Iradimed Corp. sees FY2016 EPS of $0.88-$0.90, versus prior guidance of $0.83-$0.85 and the consensus of $0.83.
For earnings history and earnings-related data on Iradimed Corp. (IRMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BayCom Corp (BCML) Misses Q1 EPS by 4c
- Southern First Bancshares, Inc. (SFST) Misses Q1 EPS by 8c
- Chemung Financial (CHMG) Tops Q1 EPS by 44c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!